I do know more more than you about the subject and you appear too lazy to study up on it but comment anyway. Nice
Looks like ARNA writes a 20M check to Eiasi pushing up the need fort a secondary offering 2-3 months earlier. Secondary better be before the CC in 3 weeks
Lets keep this post up there. This will replace 4 dollar generics in 3 years. Wait ARNA may be gone by then. Don't hide SV discovery indeed
at 6K Rx's a week they probably losing a quarter billion dollars a year between Eiasi and ARNA. Carry on. See you in the $2''s
and during the first year on the market no advertising or ease of access existed. Q Drs must take a study course to RX it and it stills outsells Belviq because it works better. Almost no marketing and it still sells better
Actually there is almost nothing good to say about ARNA. They sell an overpriced ineffective product and the rest of the world questions its trial design gives an inaccurate safety picture due to its overpopulation of younger persons in the trials. It also has insiders who refuse to by the stock
Maybe the nearby countries are even better. Some have seen a 700% increase in children refugees. It is about violence, not poverty driving this crisis.
Belviq writes a 15 day free RX and a regular RX. Q writes a 15 day starter script and then a longer regular dose RX. Please explain the difference Dumb a#$
Telecaster, there is no path to profitability with the rest of the world closed off. The day the FDA used the words" marginal efficacy " I came to this board and proclaimed correctly no other country would ever approve the product. I was correct and have profited from that proclamation. I said ARNA would not realize 10M in income from sales in year one. I was the only person correct in that proclamation. No one else was in the ballpark. I said the average person would take the drug less than 3 months. I was correct again. Most importantly from recent data the number of Dr's who Rx'ed has grown but slew have not flowed. I proclaim Dr's are abandoning ARNA just like the patents. I predicted a year ago as Dr's see enough results they would turn off to the product. Large data sets tell a meaningful story. Lies won't work anymore about the "wondrous" results for the money paid. Short more when you want a new boat Telecaster. I take my apartment in Paris as enough :). The rest to put the grandkids through Harvard
because it is fun to see the truth unfold in a profitable manner and watch the deniers carry on
When bashing is truth telling it is good. I am good. This product has no viability long term. The rest of the world's rejection is very important. If you are investing in the pipeline fine. I would never trust what management tells you however
Because the company does not want to use the inventory proceeds from the closed stores to pay back part of their loans secured by the inventory RSH wants to liquidate . The management wants to prolong the time Jack continues to draw 8 M in compensation and the board members keep getting paid too. Lenders rightfully said F off. You sell of our collateral you repay us alike amount you owe us.
they cannot sell enough to cover the cost of the salesforce , let alone make money. ARNA's cost of running the pill factory exceeds all income received from sales of the pill.